新型伤湿止痛贴膏剂体外释药规律研究

来源 :中草药 | 被引量 : 0次 | 上传用户:GAODAOQUAN
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的研究新型伤湿止痛贴膏剂(热熔压敏胶基质)体外透皮速率和释放规律。方法采用HPLC法测定透皮接收液和释放液中指标成分马钱子碱、士的宁和硫酸阿托品的量,计算其体外透皮速率和释放速率。结果马钱子碱、士的宁和硫酸阿托品在体外透皮试验中,分别以7.44%.h?1/2、10.53%.h?1/2、4.73%.h?1/2的速率恒速渗透;体外释药速率分别为10.35%.h?1/2、18.13%.h?1/2、4.88%.h?1/2,其释放过程符合Higuchi方程。结论以热熔压敏胶为基质的新型伤湿止痛贴膏剂为骨架控释型释药系统。 Objective To study the in vitro dermal penetration rate and release pattern of a new type of dampness analgesic patch (hot-melt pressure-sensitive adhesive matrix). Methods The contents of strychnine, strychnine and atropine sulfate in the transdermal receiving solution and the releasing solution were determined by HPLC, and the in vitro transdermal rate and release rate were calculated. Results The contents of brucine, strychnine and atropine sulfate were determined by in vitro transdermal test at rates of 7.44% .h 1/2, 10.53%, 1.24%, 2.37% The rate of drug release in vitro was 10.35%, h 1/2, 18.13%, h 1/2, 2.88%, h 1/2, respectively. The release rates were in accordance with the Higuchi equation. Conclusion The new hot-melt pressure-sensitive adhesive as the matrix injury analgesic painkiller paste matrix controlled release drug delivery system.
其他文献
体细胞核移植技术是目前生物技术领域的热点之一.经过数十年的发展,该技术已趋向成熟,被大量应用于哺乳动物的胚胎克隆中.本文介绍了体细胞核移植技术,论述了该技术在转基因